(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

PEVIDERM

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

PEVIDERM

ST13

US500000097846559

Class

5

Filing

97846559

Registration

7681428

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

21

Latest update

02/04/2025

Trademark type

Word

Nice classes

5

Filing date

03/20/2023

Registration date

02/04/2025

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

02/04/2025

Last transaction

02/04/2025

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

01/01/2024

First use in commerce

01/01/2024

Drawing code

4

Owner type

03

Owner location

Miami, FL

Examiner

PEISECKI, MARK

Law office

L50

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

Stratus Pharmaceuticals, Inc.

Representatives

Xavier L. Suarez

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Pharmaceutical preparations for skin woundswound care powdersgels and liquids

Publications

History of USPTO decisions and trademark events.

21 publications found

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

02/04/2025

R.PR

REGISTERED-PRINCIPAL REGISTER

02/04/2025

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

01/10/2025

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

01/10/2025

SUPC

STATEMENT OF USE PROCESSING COMPLETE

01/07/2025

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

01/06/2025

IUAF

USE AMENDMENT FILED

10/21/2024

EISU

TEAS STATEMENT OF USE RECEIVED

10/21/2024

TPEX

SOU EXTENSION RECEIVED WITH TEAS PETITION

10/21/2024

NREV

NOTICE OF REVIVAL - E-MAILED

10/21/2024

PETG

PETITION TO REVIVE-GRANTED

10/21/2024

PROA

TEAS PETITION TO REVIVE RECEIVED

10/21/2024

MAB6

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED

10/21/2024

ABN6

ABANDONMENT - NO USE STATEMENT FILED

10/21/2024

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

03/19/2024

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

01/23/2024

PUBO

PUBLISHED FOR OPPOSITION

01/23/2024

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

01/03/2024

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

12/19/2023

DOCK

ASSIGNED TO EXAMINER

12/15/2023

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

04/11/2023

Continuous trademark protection

Get notified about every new filing that threatens PEVIDERM or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.